cd141 (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
91
Structured Review
Miltenyi Biotec
cd141
Cd141, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 91/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd141/CD141+(BDCA-3)+MicroBead+Kit%2C+human/10__1080_slash_2162402x__2026__2695692-57-7-9
Average 91 stars, based on 10 article reviews
Cd141, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 91/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd141/CD141+(BDCA-3)+MicroBead+Kit%2C+human/10__1080_slash_2162402x__2026__2695692-57-7-9
Average 91 stars, based on 10 article reviews
cd141 - by Bioz Stars,
2026-10
91/100 stars
Images
Related Articles
Selection:Article Title: Intratumoral administration of the immunologic adjuvant AS01 B in combination with autologous CD1c (BDCA-1) + /CD141 (BDCA-3) + myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma. Article Snippet: .. First, CD14+ and CD19+ cells were depleted with the CliniMACS CD14 and CD19 reagents followed by a positive selection of CD1c (BDCA- 1)+ myDC and other:Article Title: Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DC Article Snippet: CD141 , APC , Article Title: Ex vivo-generated conventional dendritic cells type 1 and type 2 from blood progenitors induce potent antigen-specific T-cell immunity Article Snippet: Alternatively, DCs were enriched by MACS using CD141-Microbeads (130-090-512, Miltenyi Biotec) and Incubation:Article Title: Adipose-derived dual cell therapy enhances arteriogenesis and limb preservation through vascular integration in critical limb ischemia Article Snippet: VMSCs and ADSCs were blocked with a human FcR blocking reagent (Miltenyi Biotec), then centrifuged at 500 g at 4 °C for 5 min. .. The cells were incubated with allophycocyanin (APC)-conjugated antibodies against CD29, CD34, CD44, CD45, CD73, CD90, CD105, and Article Title: Decreased levels and function of dendritic cells in blood and airways predict COVID ‐19 severity Article Snippet: .. After Live/Dead Blue staining (Invitrogen), cells were incubated with human FcR blocking reagent (Miltenyi Biotec, Bergisch Gladbach, Germany) and then stained with antibodies against surface proteins: CD1c (AD5‐8E7; Miltenyi Biotec), CD3 (SK7; Becton, Dickinson and Company (BD), Franklin Lakes, NJ, USA), CD11c (B‐Ly6; BD), CD14 (M5E2; BD), CD16 (3GE; BioLegend, San Diego, CA, USA), CD19 (HIB19; BioLegend), CD20 (L27; BD), CD45 (HI30; BD), CD56 (HCD56; BD), CD62L (SK11; BD), CD66abce (TET2; Miltenyi Biotec), CD86 (2331; BD), CD123 (7G3; BD), Article Title: Decreased levels and function of dendritic cells in blood and airways predict COVID ‐19 severity Article Snippet: .. Cells were washed with PBS and stained using Live/Dead Blue (Invitrogen, Thermo Fisher Scientific), incubated with human FcR blocking reagent (Miltenyi Biotec), and stained at 4°C for 20 min with antibodies against the following surface proteins: CD1c (AD5‐8E7; Miltenyi Biotec), CD3 (SK7; BD), CD11c (B‐Ly6; BD), CD14 (M5E2; BD), CD16 (3GE; BioLegend), CD19 (HIB19; BioLegend), CD20 (L27; BD), CD45 (HI30; BD), CD56 (HCD56; BD), CD66abce (TET2; Miltenyi Biotec), CD86 (2331; BD), CD123 (7G3; BD), Isolation:Article Title: Intratumoral administration of the immunologic adjuvant AS01 B in combination with autologous CD1c (BDCA-1) + /CD141 (BDCA-3) + myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma. Article Snippet: First, CD14+ and CD19+ cells were depleted with the CliniMACS CD14 and CD19 reagents followed by a positive selection of CD1c (BDCA- 1)+ myDC and CD141 (BDCA- 3)+ myDC by using CliniMACS CD1c (BDCA- 1)- biotin microbeads, CliniMACS CD141 (BDCA- 3)- biotin microbeads and CliniMACS Anti- Biotin Reagent (Miltenyi) using the CliniMACS Prodigy platform (Miltenyi Biotec, Bergisch Gladbach, Germany). .. The isolated CD1c (BDCA- 1)+ and Centrifugation:Article Title: Intratumoral administration of the immunologic adjuvant AS01 B in combination with autologous CD1c (BDCA-1) + /CD141 (BDCA-3) + myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma. Article Snippet: First, CD14+ and CD19+ cells were depleted with the CliniMACS CD14 and CD19 reagents followed by a positive selection of CD1c (BDCA- 1)+ myDC and CD141 (BDCA- 3)+ myDC by using CliniMACS CD1c (BDCA- 1)- biotin microbeads, CliniMACS CD141 (BDCA- 3)- biotin microbeads and CliniMACS Anti- Biotin Reagent (Miltenyi) using the CliniMACS Prodigy platform (Miltenyi Biotec, Bergisch Gladbach, Germany). .. The isolated CD1c (BDCA- 1)+ and Saline:Article Title: Intratumoral administration of the immunologic adjuvant AS01 B in combination with autologous CD1c (BDCA-1) + /CD141 (BDCA-3) + myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma. Article Snippet: First, CD14+ and CD19+ cells were depleted with the CliniMACS CD14 and CD19 reagents followed by a positive selection of CD1c (BDCA- 1)+ myDC and CD141 (BDCA- 3)+ myDC by using CliniMACS CD1c (BDCA- 1)- biotin microbeads, CliniMACS CD141 (BDCA- 3)- biotin microbeads and CliniMACS Anti- Biotin Reagent (Miltenyi) using the CliniMACS Prodigy platform (Miltenyi Biotec, Bergisch Gladbach, Germany). .. The isolated CD1c (BDCA- 1)+ and Suspension:Article Title: Intratumoral administration of the immunologic adjuvant AS01 B in combination with autologous CD1c (BDCA-1) + /CD141 (BDCA-3) + myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma. Article Snippet: First, CD14+ and CD19+ cells were depleted with the CliniMACS CD14 and CD19 reagents followed by a positive selection of CD1c (BDCA- 1)+ myDC and CD141 (BDCA- 3)+ myDC by using CliniMACS CD1c (BDCA- 1)- biotin microbeads, CliniMACS CD141 (BDCA- 3)- biotin microbeads and CliniMACS Anti- Biotin Reagent (Miltenyi) using the CliniMACS Prodigy platform (Miltenyi Biotec, Bergisch Gladbach, Germany). .. The isolated CD1c (BDCA- 1)+ and Staining:Article Title: Decreased levels and function of dendritic cells in blood and airways predict COVID ‐19 severity Article Snippet: .. After Live/Dead Blue staining (Invitrogen), cells were incubated with human FcR blocking reagent (Miltenyi Biotec, Bergisch Gladbach, Germany) and then stained with antibodies against surface proteins: CD1c (AD5‐8E7; Miltenyi Biotec), CD3 (SK7; Becton, Dickinson and Company (BD), Franklin Lakes, NJ, USA), CD11c (B‐Ly6; BD), CD14 (M5E2; BD), CD16 (3GE; BioLegend, San Diego, CA, USA), CD19 (HIB19; BioLegend), CD20 (L27; BD), CD45 (HI30; BD), CD56 (HCD56; BD), CD62L (SK11; BD), CD66abce (TET2; Miltenyi Biotec), CD86 (2331; BD), CD123 (7G3; BD), Article Title: Decreased levels and function of dendritic cells in blood and airways predict COVID ‐19 severity Article Snippet: .. Cells were washed with PBS and stained using Live/Dead Blue (Invitrogen, Thermo Fisher Scientific), incubated with human FcR blocking reagent (Miltenyi Biotec), and stained at 4°C for 20 min with antibodies against the following surface proteins: CD1c (AD5‐8E7; Miltenyi Biotec), CD3 (SK7; BD), CD11c (B‐Ly6; BD), CD14 (M5E2; BD), CD16 (3GE; BioLegend), CD19 (HIB19; BioLegend), CD20 (L27; BD), CD45 (HI30; BD), CD56 (HCD56; BD), CD66abce (TET2; Miltenyi Biotec), CD86 (2331; BD), CD123 (7G3; BD), Blocking Assay:Article Title: Decreased levels and function of dendritic cells in blood and airways predict COVID ‐19 severity Article Snippet: .. After Live/Dead Blue staining (Invitrogen), cells were incubated with human FcR blocking reagent (Miltenyi Biotec, Bergisch Gladbach, Germany) and then stained with antibodies against surface proteins: CD1c (AD5‐8E7; Miltenyi Biotec), CD3 (SK7; Becton, Dickinson and Company (BD), Franklin Lakes, NJ, USA), CD11c (B‐Ly6; BD), CD14 (M5E2; BD), CD16 (3GE; BioLegend, San Diego, CA, USA), CD19 (HIB19; BioLegend), CD20 (L27; BD), CD45 (HI30; BD), CD56 (HCD56; BD), CD62L (SK11; BD), CD66abce (TET2; Miltenyi Biotec), CD86 (2331; BD), CD123 (7G3; BD), Article Title: Decreased levels and function of dendritic cells in blood and airways predict COVID ‐19 severity Article Snippet: .. Cells were washed with PBS and stained using Live/Dead Blue (Invitrogen, Thermo Fisher Scientific), incubated with human FcR blocking reagent (Miltenyi Biotec), and stained at 4°C for 20 min with antibodies against the following surface proteins: CD1c (AD5‐8E7; Miltenyi Biotec), CD3 (SK7; BD), CD11c (B‐Ly6; BD), CD14 (M5E2; BD), CD16 (3GE; BioLegend), CD19 (HIB19; BioLegend), CD20 (L27; BD), CD45 (HI30; BD), CD56 (HCD56; BD), CD66abce (TET2; Miltenyi Biotec), CD86 (2331; BD), CD123 (7G3; BD), |